Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

ASTONEA LABS LIMITED

Healthcare › Pharmaceuticals & Biotechnology
₹323.00
at close · 19 Oct 2026
▼ 1.00 (-0.31%)

Latest filings

  1. Change in Corporate Identification Number (CIN) after altering Object Clause · Compliance
  2. Astonea Labs incorporates new subsidiary Longevity Science Pvt Ltd · Strategic Transactions
  3. Routine SEBI Reg 74(5) certificate filing for Q2 FY27 · Compliance
All filings ↓
Ask Nexa about ASTONEA LABS LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Manufactures and sells pharmaceutical products from a facility at Village Haripur, Panchkula, Haryana, generating Rs 147.58 crore in FY26 revenue, up 51% from Rs 97.52 crore the year before. The revenue base is built on third-party manufacturing orders combined with own-brand distribution, with the company investing in distribution channels and brand building during the year. Profitability softened: standalone EBITDA fell to Rs 13.80 crore (margin 9.35%) and standalone PAT slipped to Rs 4.52 crore, while consolidated PAT rose to Rs 5.35 crore. A fire on 27 April 2026 at the Panchkula factory caused Rs 9.39 crore of damage to building, plant, machinery and stocks, with the insurance claim still pending. Capital from a Rs 37.67 crore IPO in June 2025 was partly redirected into a 25.74% stake in Damaira Pharmaceuticals (Rs 6.25 crore) and into a US subsidiary, Astonea LLC in Wyoming, while the company also terminated its agreements with Astonea One Private Limited.

Operating scale
FY26 revenue
Rs 147.58 croreFY26
Manufacturing facility
Village Haripur, Panchkula, Haryana
Regulatory inspection cleared
SBDMA, Ministry of Health, Republic of Yemen
IPO proceeds raised (June 2025)
Rs 37.67 croreFY26
Stake in Damaira Pharmaceuticals
25.74% for Rs 6.25 croreMar 2026
Fire incident loss at Panchkula factory
Rs 9.39 crore27 Apr 2026
Who pays it
Pharmaceutical distributors and buyers of third-party manufacturing services; consumers of its own branded products.
Biggest cost
Materials/raw materials at 69.6% of revenue (FY26), with other operating expenses at 19.1% and employee cost at 5.2%.
Kind of business
Small-cap pharmaceutical manufacturer on BSE SME, growing top line but with margin pressure and a recent uninsured factory fire loss.
Where it sits
BSE SME-listed pharmaceutical company manufacturing from Panchkula, Haryana, with a recently formed US subsidiary and a minority stake in Damaira Pharmaceuticals.
Market Cap
₹340 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
11.3%·
ROCE (FY26)
ROE — · margin —
Leverage
—·
Debt / Equity · borrowings not filed
Moves on a normal day
1.81%·
Median daily move
Last 202 sessions · the yardstick for filing-day moves
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#143/158
ROCE#116/183

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Not enough history to assess.

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from ASTONEA LABS LIMITED's filed financials and exchange disclosures

What does ASTONEA LABS LIMITED do?

ASTONEA LABS LIMITED is a Pharmaceuticals & Biotechnology company listed on BSE.

How much does the ASTONEA LABS LIMITED share price move in a day?

On a typical session ASTONEA LABS LIMITED moves 1.81% — that is the median absolute close-to-close move across its last 202 trading days. MarketPing measures each filing's price reaction against it.

Where can I track ASTONEA LABS LIMITED's announcements?

Every NSE and BSE filing by ASTONEA LABS LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.